- Oncology trials are growing in complexity, both in design and execution.
- Precision medicine is leading to hyper-fractionated patient populations in biomarker-driven studies.
- Sponsors and CROs must evolve their operating models to enhance patient centricity in this shifting landscape.
- This session presents a 360° Site Support model that puts patients at the center — with proven success in oncology trials.
